Project Grant R21CA309323

Federal Grant Award Summary

The National Cancer Institute (NCI) awarded a $457,252 Project Grant to Sloan-Kettering Institute for Cancer Research under the Cancer Cause and Prevention Research program (CFDA 93.393) on June 10, 2026, with a completion date of May 31, 2028. The award supports the development and implementation of RECONJOINT, a web-based decision support tool designed to improve shared decision-making for breast reconstruction surgery. The tool utilizes adaptive choice-based conjoint (ACBC) analysis to systematically elicit and integrate individual patient preferences into treatment planning, addressing a critical gap in current surgical decision-making processes where 40% of patients report dissatisfaction and decisional regret.

Under Aim 1, the awardee will design a comprehensive implementation toolkit informed by focus groups and developed collaboratively with patients, providers, and patient advocates. The toolkit will include a treatment preferences report, educational video content on the tool and existing evidence, and recommendations for clinical integration of patient preferences into shared decision-making. Under Aim 2, the project will conduct a pilot cluster-randomized evaluation to assess the feasibility, acceptability, and preliminary efficacy of the RECONJOINT intervention in a clinical setting. These deliverables directly address the program's objectives to identify risk reduction strategies and develop preventive interventions while advancing patient-centered cancer care outcomes.